{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:02:00Z","timestamp":1783652520334,"version":"3.55.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nephrol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Focal segmental glomerulosclerosis (FSGS) is a common cause of end-stage kidney disease requiring kidney transplantation and can recur in the allograft in 30-80% of recipients resulting in reduced graft survival. Plasmapheresis has shown efficacy in treating some cases of recurrent FSGS but isolated plasmapheresis has not demonstrated efficacy in preventing recurrent FSGS. Rituximab has had anecdotal success in preventing recurrence in a single center study but has not been studied in combination with plasmapheresis for preventing FSGS recurrence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We are conducting a randomized, controlled, multicenter clinical trial of adult and pediatric kidney transplant recipients with primary FSGS to assess whether plasmapheresis in combination with rituximab prevents recurrent disease post-transplantation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Rituximab combined with plasmapheresis is a promising, novel therapy to prevent recurrent FSGS, a disease with limited therapeutic options and no consensus guidelines for prevention or treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p><jats:ext-link>https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03763643<\/jats:ext-link>, identifier NCT03763643. <\/jats:p><\/jats:sec>","DOI":"10.3389\/fneph.2023.1181076","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T15:29:17Z","timestamp":1684164557000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-kidney transplant (PRI-VENT FSGS): protocol and study design"],"prefix":"10.3389","volume":"3","author":[{"given":"Michelle N.","family":"Rheault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margret","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen Tsai","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanche","family":"Chavers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireile El","family":"Ters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouba","family":"Garro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasheed","family":"Gbadegesin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Govil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsay","family":"Harshman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay K.","family":"Israni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Riad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Sageshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie P.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S.","family":"Verghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.3390\/jcm11123292","article-title":"Biomarkers in primary focal segmental glomerulosclerosis in optimal diagnostic-therapeutic strategy","volume":"11","author":"Musiala","year":"2022","journal-title":"J Clin Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2009.01261.x","article-title":"Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review","volume":"14","author":"Vinai","year":"2010","journal-title":"Pediatr transplant"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013080852","article-title":"Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence","volume":"25","author":"Ding","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31819f12be","article-title":"Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence","volume":"87","author":"Hickson","year":"2009","journal-title":"Transplantation"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03060316","article-title":"Long-term outcome of kidney transplantation in recipients with focal segmental glomerulosclerosis","volume":"11","author":"Francis","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-3994-3","article-title":"Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings","volume":"33","author":"Pelletier","year":"2018","journal-title":"Pediatr nephrol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000454947","article-title":"Unsuccessful treatment with abatacept in recurrent focal segmental glomerulosclerosis after kidney transplantation","volume":"7","author":"Kristensen","year":"2017","journal-title":"Case Rep Nephrol Dial"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2014.882238","article-title":"Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient","volume":"36","author":"Cho","year":"2014","journal-title":"Ren Fail"},{"key":"B9","doi-asserted-by":"publisher","first-page":"389542","DOI":"10.1155\/2011\/389542","article-title":"Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: effect of rituximab","volume":"2011","author":"Sethna","year":"2011","journal-title":"J Transplant"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182088b67","article-title":"Treatment of recurrent focal segmental glomerular sclerosis posttransplant with a multimodal approach including high-galactose diet and oral galactose supplementation","volume":"91","author":"Jhaveri","year":"2011","journal-title":"Transplantation"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604043341402","article-title":"Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis","volume":"334","author":"Savin","year":"1996","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/petr.12185","article-title":"Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients","volume":"18","author":"Straatmann","year":"2014","journal-title":"Pediatr transplant"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s004670100008","article-title":"Long-term plasmapheresis and protein a column treatment of recurrent FSGS","volume":"16","author":"Belson","year":"2001","journal-title":"Pediatr nephrol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.02.061","article-title":"Plasmapheresis for the prophylaxis and treatment of recurrent focal segmental glomerulosclerosis following renal transplant","volume":"37","author":"Valdivia","year":"2005","journal-title":"Transplant Proc"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001160","article-title":"Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: clinical outcomes","volume":"101","author":"Garrouste","year":"2017","journal-title":"Transplantation"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304572","article-title":"Abatacept in B7-1-positive proteinuric kidney disease","volume":"369","author":"Yu","year":"2013","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.03.028","article-title":"High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children","volume":"44","author":"Raafat","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1399-3046.2011.01478.x","article-title":"Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantation","volume":"15","author":"Gonzalez","year":"2011","journal-title":"Pediatr transplant"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200103150-00008","article-title":"Effect of pre-and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children","volume":"71","author":"Ohta","year":"2001","journal-title":"Transplantation"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.01112.x","article-title":"Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients","volume":"5","author":"Gohh","year":"2005","journal-title":"Am J Transplant"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e13154","DOI":"10.1111\/petr.13154","article-title":"The effect of peri-transplant plasmapheresis in the prevention of recurrent FSGS","volume":"22","author":"Verghese","year":"2018","journal-title":"Pediatr transplantation"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60541-9","article-title":"Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"384","author":"Iijima","year":"2014","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00570109","article-title":"Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis","volume":"4","author":"Fernandez-Fresnedo","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis","volume":"3","author":"Fornoni","year":"2011","journal-title":"Sci Transl Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"374213","DOI":"10.1155\/2011\/374213","article-title":"The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: a systematic review","volume":"2011","author":"Araya","year":"2011","journal-title":"J Transplant"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2012.01462.x","article-title":"Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation","volume":"25","author":"Audard","year":"2012","journal-title":"Transpl Int"},{"key":"B27","doi-asserted-by":"publisher","first-page":"256ra136","DOI":"10.1126\/scitranslmed.3008538","article-title":"A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation","volume":"6","author":"Delville","year":"2014","journal-title":"Sci Transl Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021060794","article-title":"Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology","volume":"33","author":"Watts","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.21037\/atm-21-3988","article-title":"The important roles and molecular mechanisms of annexin A2 autoantibody in children with nephrotic syndrome","volume":"9","author":"Ye","year":"2021","journal-title":"Ann Transl Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp500","article-title":"Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS)","volume":"25","author":"Canaud","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08970719","article-title":"Recurrence of FSGS after kidney transplantation in adults","volume":"15","author":"Uffing","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-4052-x","article-title":"Effect of different rituximab regimens on b cell depletion and time to relapse in children with steroid-dependent nephrotic syndrome","volume":"34","author":"Hogan","year":"2019","journal-title":"Pediatr nephrol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v11.i7.303","article-title":"Rituximab or plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis after kidney transplantation: a systematic review and meta-analysis","volume":"11","author":"Boonpheng","year":"2021","journal-title":"World J Transplant"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2011.195","article-title":"Clinical trial of focal segmental glomerulosclerosis in children and young adults","volume":"80","author":"Gipson","year":"2011","journal-title":"Kidney Int"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00427-1","article-title":"Therapeutic trials in adult FSGS: lessons learned and the road forward","volume":"17","author":"De Vriese","year":"2021","journal-title":"Nat Rev Nephrol"}],"container-title":["Frontiers in Nephrology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2023.1181076\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T15:29:22Z","timestamp":1684164562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2023.1181076\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":35,"alternative-id":["10.3389\/fneph.2023.1181076"],"URL":"https:\/\/doi.org\/10.3389\/fneph.2023.1181076","relation":{},"ISSN":["2813-0626"],"issn-type":[{"value":"2813-0626","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,15]]},"article-number":"1181076"}}